{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:21:16Z","timestamp":1791062476494,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd010952","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T00:00:00Z","timestamp":1437091200000}}],"reference-count":187,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010952.pub2","type":"journal-article","created":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T13:12:16Z","timestamp":1437138736000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)"],"prefix":"10.1002","volume":"2015","author":[{"given":"F\u00e9line PB","family":"Kroon","sequence":"first","affiliation":[{"name":"Leiden University Medical Center; Department of Rheumatology; Leiden Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart RA","family":"van der Burg","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center; Department of Rheumatology; Leiden Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Ramiro","sequence":"additional","affiliation":[{"name":"Academic Medical Center, University of Amsterdam; Department of Clinical Immunology and Rheumatology; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert BM","family":"Landew\u00e9","sequence":"additional","affiliation":[{"name":"Academic Medical Center, University of Amsterdam; Department of Clinical Immunology and Rheumatology; Amsterdam Netherlands"},{"name":"Atrium Medical Centre; Department of Rheumatology; Herleen Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle","family":"Buchbinder","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University; Monash Department of Clinical Epidemiology, Cabrini Hospital; Suite 41, Cabrini Medical Centre 183 Wattletree Road Malvern Victoria Australia 3144"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Falzon","sequence":"additional","affiliation":[{"name":"Columbia University Medical Center; Center for Behavioral Cardiovascular Health; PH9 Room E319 622 West 168th St New York NY USA 10032"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9sir\u00e9e","family":"van der Heijde","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center; Department of Rheumatology; Leiden Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,7,17]]},"reference":[{"issue":"Suppl 2","key":"10.1002\/14651858.CD010952.pub2-BIB0002|cit1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/030006057700502S19","article-title":"A comparative study of Butacote and naproxen in ankylosing spondylitis","volume":"5","author":"Ansell","year":"1977","journal-title":"Journal of International Medical Research"},{"issue":"5","key":"10.1002\/14651858.CD010952.pub2-BIB0001|cit2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/ard.37.5.436","article-title":"A comparative study of Butacote and Naprosyn in ankylosing spondylitis","volume":"37","author":"Ansell","year":"1978","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD010952.pub2-BIB0003|cit3","first-page":"70","article-title":"Double-blind, parallel clinical trial of tenoxicam (Ro 12-0068) versus piroxicam in patients with ankylosing spondylitis","volume":"9","author":"Astorga","year":"1987","journal-title":"European Journal of Rheumatology and Inflammation"},{"issue":"9","key":"10.1002\/14651858.CD010952.pub2-BIB0004|cit4","first-page":"1805","article-title":"Celecoxib is efficacious and well tolerated in treating signs and symptoms of ankylosing spondylitis","volume":"33","author":"Barkhuizen","year":"2006","journal-title":"Journal of Rheumatology"},{"issue":"7","key":"10.1002\/14651858.CD010952.pub2-BIB0005|cit5","first-page":"1200","article-title":"The efficacy and tolerability of aceclofenac in the treatment of patients with ankylosing spondylitis: a multicenter controlled clinical trial. Aceclofenac Indomethacin Study Group","volume":"23","author":"Batlle-Gualda","year":"1996","journal-title":"Journal of Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD010952.pub2-BIB0006|cit6","first-page":"60","article-title":"Retardation of ossification of the lumbar vertebral column in ankylosing spondylitis by means of phenylbutazone","volume":"5","author":"Boersma","year":"1976","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"3 Suppl 2","key":"10.1002\/14651858.CD010952.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0049-0172(86)80015-4","article-title":"Treatment of ankylosing spondylitis with oxaprozin: A comparison with indomethacin","volume":"15","author":"Caldwell","year":"1986","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"17","key":"10.1002\/14651858.CD010952.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1001\/jama.1979.03300170031022","article-title":"Sulindac in ankylosing spondylitis. Double-blind evaluation of sulindac and indomethacin","volume":"242","author":"Calin","year":"1979","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD010952.pub2-BIB0009|cit9","first-page":"29","article-title":"A 12-week double-blind study of the efficacy, safety and tolerance of pirazolac b.i.d. compared with indomethacin t.i.d. in patients with ankylosing spondylitis","volume":"16","author":"Carcassi","year":"1990","journal-title":"Drugs Under Experimental and Clinical Research"},{"issue":"5","key":"10.1002\/14651858.CD010952.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/03009749409103723","article-title":"Ximoprofen in ankylosing spondylitis. A double blind placebo controlled dose ranging study","volume":"23","author":"Dougados","year":"1994","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD010952.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/rheumatology\/38.3.235","article-title":"Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial","volume":"38","author":"Dougados","year":"1999","journal-title":"Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD010952.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/1529-0131(200101)44:1<180::AID-ANR24>3.0.CO;2-K","article-title":"Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug","volume":"44","author":"Dougados","year":"2001","journal-title":"Arthritis and Rheumatism"},{"issue":"4A","key":"10.1002\/14651858.CD010952.pub2-BIB0013|cit13","first-page":"660","article-title":"Meclofenamate sodium in the treatment of ankylosing spondylitis. Report of a European double-blind controlled multicenter study","volume":"33","author":"Ebner","year":"1983","journal-title":"Arzneimittel-Forschung"},{"issue":"2","key":"10.1002\/14651858.CD010952.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/BF02032359","article-title":"A comparison of diflunisal and phenylbutazone in the treatment of ankylosing spondylitis","volume":"5","author":"Franssen","year":"1986","journal-title":"Clinical Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD010952.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1185\/03007997709108987","article-title":"Treatment of ankylosing spondylitis with flurbiprofen and indomethacin","volume":"5","author":"Good","year":"1977","journal-title":"Current Medical Research and Opinion"},{"issue":"8","key":"10.1002\/14651858.CD010952.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/00007611-197708000-00014","article-title":"Management of ankylosing spondylitis with flurbiprofen or indomethacin","volume":"70","author":"Mena","year":"1977","journal-title":"Southern Medical Journal"},{"issue":"21","key":"10.1002\/14651858.CD010952.pub2-BIB0017|cit17","first-page":"597","article-title":"Treatment of spondylitis ankylosans: Controlled comparative study with tiaprofenic acid and diclofenac","volume":"80","author":"Heinrichs","year":"1985","journal-title":"Medizinische Klinik"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/rheumatology\/15.5.37","article-title":"Double-blind study of ketoprofen and phenylbutazone in ankylosing spondylitis","volume":"Suppl","author":"Jessop","year":"1976","journal-title":"Rheumatology and Rehabilitation"},{"issue":"4B","key":"10.1002\/14651858.CD010952.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0002-9343(86)90082-3","article-title":"Efficacy of diclofenac in ankylosing spondylitis","volume":"80","author":"Calabro","year":"1986","journal-title":"American Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010952.pub2-BIB0020|cit20","first-page":"118","article-title":"A double blind comparison of diclofenac and indomethacin in the treatment of ankylosing spondylitis","volume":"14","author":"Khan","year":"1987","journal-title":"Journal of Rheumatology"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD010952.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0049-0172(85)80016-0","article-title":"Diclofenac in the treatment of ankylosing spondylitis: review of worldwide clinical experience and report of a double-blind comparison with indomethacin","volume":"15","author":"Khan","year":"1985","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD010952.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/rheumatology\/23.1.52","article-title":"Tolerability and efficacy of a slow-release indomethacin tablet in ankylosing spondylitis","volume":"23","author":"Lehtinen","year":"1984","journal-title":"British Journal of Rheumatology"},{"issue":"3A","key":"10.1002\/14651858.CD010952.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0002-9343(86)90129-4","article-title":"Flurbiprofen in the treatment of ankylosing spondylitis. A comparison with indomethacin","volume":"80","author":"Lomen","year":"1986","journal-title":"American Journal of Medicine"},{"issue":"3A","key":"10.1002\/14651858.CD010952.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0002-9343(86)90128-2","article-title":"Flurbiprofen in the treatment of ankylosing spondylitis. A comparison with phenylbutazone","volume":"80","author":"Lomen","year":"1986","journal-title":"American Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010952.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00607674","article-title":"Treatment of ankylosing spondylitis with flurbiprofen or phenylbutazone","volume":"11","author":"Mena","year":"1977","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"21","key":"10.1002\/14651858.CD010952.pub2-BIB0026|cit26","first-page":"2619","article-title":"Ketoprofen in ankylosing spondylitis","volume":"35","author":"Muller-Fassbender","year":"1985","journal-title":"Therapiewoche"},{"issue":"17-8","key":"10.1002\/14651858.CD010952.pub2-BIB0027|cit27","first-page":"1485","article-title":"Comparison of naproxen and piroxicam in rheumatoid arthritis and Bechterew's syndrome. A double-blind parallel multicenter study","volume":"106","author":"Myklebust","year":"1986","journal-title":"Tidsskrift for Den Norske L\u00e6geforening"},{"issue":"3","key":"10.1002\/14651858.CD010952.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/rheumatology\/19.3.193","article-title":"A comparative study of diclofenac and sulindac in ankylosing spondylitis","volume":"19","author":"Nahir","year":"1980","journal-title":"Rheumatology and Rehabilitation"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/03009747809095674","article-title":"Proquazone (Biarison) and indomethacin (Indocid) in the treatment of ankylosing spondylitis. Two comparative, clinical, double-blind studies","volume":"21","author":"Nissil\u00e4","year":"1978","journal-title":"Scandinavian Journal of Rheumatology. Supplement"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/03009747809095674","article-title":"Proquazone (Biarison) and indomethacin (Indocid) in the treatment of ankylosing spondylitis. Two comparative, clinical, double-blind studies","volume":"21","author":"Nissil\u00e4","year":"1978","journal-title":"Scandinavian Journal of Rheumatology. Supplement"},{"issue":"2","key":"10.1002\/14651858.CD010952.pub2-BIB0031|cit31","first-page":"23","article-title":"A comparative study of nabumetone and indomethacin in ankylosing spondylitis","volume":"11","author":"Palferman","year":"1991","journal-title":"European Journal of Rheumatology and Inflammation"},{"issue":"7","key":"10.1002\/14651858.CD010952.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0011-393X(05)80777-5","article-title":"Aceclofenac versus naproxen in the treatment of ankylosing spondylitis: A double-blind, controlled study","volume":"55","author":"Pasero","year":"1994","journal-title":"Current Therapeutic Research - Clinical and Experimental"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0033|cit33","first-page":"102","article-title":"NSAIDs retard radiographic spinal progression over two years in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis","volume":"70","author":"Poddubnyy","year":"2011","journal-title":"Zeitschrift fur Rheumatologie"},{"issue":"10","key":"10.1002\/14651858.CD010952.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1136\/annrheumdis-2011-201252","article-title":"Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort","volume":"71","author":"Poddubnyy","year":"2012","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0035|cit35","first-page":"1","article-title":"Tolfenamic acid in ankylosing spondylarthritis: a double-blind comparison to indomethacin","volume":"36","author":"Rejholec","year":"1980","journal-title":"Scandinavian Journal of Rheumatology. Supplement"},{"issue":"2","key":"10.1002\/14651858.CD010952.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/030006058801600210","article-title":"Oxaprozin versus diclofenac sodium in the treatment of ankylosing spondylitis","volume":"16","author":"Santo","year":"1988","journal-title":"Journal of International Medical Research"},{"issue":"10","key":"10.1002\/14651858.CD010952.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1185\/03007999009112691","article-title":"Tenoxicam compared with diclofenac in patients with ankylosing spondylitis","volume":"11","author":"Schwarzer","year":"1990","journal-title":"Current Medical Research and Opinion"},{"issue":"3","key":"10.1002\/14651858.CD010952.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/ard.2007.075309","article-title":"Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study","volume":"67","author":"Sieper","year":"2008","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0039|cit39","first-page":"126","article-title":"A controlled study of flufenamic acid in ankylosing spondylitis. A preliminary report","volume":"Suppl","author":"Simpson","year":"1966","journal-title":"Annals of Physical Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010952.pub2-BIB0040|cit40","first-page":"40","article-title":"Comparison of piroxicam with indomethacin in ankylosing spondylitis: a double-blind crossover trial","volume":"35","author":"Sydnes","year":"1981","journal-title":"British Journal of Clinical Practice"},{"issue":"3","key":"10.1002\/14651858.CD010952.pub2-BIB0041|cit41","first-page":"426","article-title":"A double blind multicenter trial comparing piroxicam and indomethacin in ankylosing spondylitis with long-term follow-up","volume":"36","author":"Tannenbaum","year":"1984","journal-title":"Current Therapeutic Research - Clinical and Experimental"},{"issue":"11","key":"10.1002\/14651858.CD010952.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1136\/ard.2004.029611","article-title":"Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis","volume":"64","author":"Gossec","year":"2005","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4","key":"10.1002\/14651858.CD010952.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.20985","article-title":"Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study","volume":"52","author":"Heijde","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"7","key":"10.1002\/14651858.CD010952.pub2-BIB0044|cit44","first-page":"1194","article-title":"Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial","volume":"23","author":"Villa Alc\u00e1zar","year":"1996","journal-title":"Journal of Rheumatology"},{"issue":"10","key":"10.1002\/14651858.CD010952.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1136\/annrheumdis-2012-201370","article-title":"Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis","volume":"71","author":"Kroon","year":"2012","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"6","key":"10.1002\/14651858.CD010952.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.21054","article-title":"Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial","volume":"52","author":"Wanders","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"10","key":"10.1002\/14651858.CD010952.pub2-BIB0047|cit47","first-page":"637","article-title":"A comparison of indoprofen and indomethacin in the treatment of ankylosing spondylitis","volume":"3","author":"Amstrong","year":"1984","journal-title":"Pharmatherapeutica"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0048|cit48","first-page":"139","article-title":"A comparative study of benoxaprofen and indomethacin in ankylosing spondylitis","volume":"6","author":"Bird","year":"1980","journal-title":"Journal of Rheumatology. Supplement"},{"issue":"670","key":"10.1002\/14651858.CD010952.pub2-BIB0049|cit49","first-page":"309","article-title":"A comparison of flurbiprofen with naproxen in ankylosing spondylitis","volume":"92","author":"Burry","year":"1980","journal-title":"New Zealand Medical Journal"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1185\/03007998209110113","article-title":"A double-blind crossover study comparing tolmetin sodium and naproxen in the treatment of ankylosing spondylitis","volume":"7","author":"Byron","year":"1982","journal-title":"Current Medical Research and Opinion"},{"issue":"5943","key":"10.1002\/14651858.CD010952.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/bmj.4.5943.496","article-title":"Double-bind cross-over trial of flurbiprofen and phenylbutazone in ankylosing spondylitis","volume":"4","author":"Calin","year":"1974","journal-title":"British Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD010952.pub2-BIB0052|cit52","first-page":"277","article-title":"A comparative study of benoxaprofen and ketoprofen in ankylosing spondylitis","volume":"5","author":"Charlot","year":"1982","journal-title":"European Journal of Rheumatology and Inflammation"},{"issue":"8","key":"10.1002\/14651858.CD010952.pub2-BIB0053|cit53","first-page":"1167","article-title":"A double blind crossover placebo controlled trial of ximoprofen in as","volume":"16","author":"Dougados","year":"1989","journal-title":"Journal of Rheumatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010952.pub2-BIB0054|cit54","first-page":"157S","article-title":"Isoxicam vs ketoprofen in ankylosing spondylitis","volume":"22","author":"Doury","year":"1986","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD010952.pub2-BIB0055|cit55","first-page":"69","article-title":"Double-blind comparison of tolmetin sodium and indomethacin in ankylosing spondylitis","volume":"9","author":"Esdaile","year":"1982","journal-title":"Journal of Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD010952.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/rheumatology\/19.3.189","article-title":"Sulindac and indomethacin in the treatment of ankylosing spondylitis: a double-blind cross-over study","volume":"19","author":"Gibson","year":"1980","journal-title":"Rheumatology and Rehabilitation"},{"issue":"3","key":"10.1002\/14651858.CD010952.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/rheumatology\/16.3.158","article-title":"A trial of feprazone in ankylosing spondylitis","volume":"16","author":"Harkness","year":"1977","journal-title":"Rheumatology and Rehabilitation"},{"issue":"2","key":"10.1002\/14651858.CD010952.pub2-BIB0058|cit58","first-page":"37","article-title":"Morning stiffness and nightime pain in ankylosing spondylitis. A comparison between enteric-coated and plain naproxen tablets","volume":"12","author":"Johnsen","year":"1992","journal-title":"European Journal of Rheumatology & Inflammation"},{"issue":"3","key":"10.1002\/14651858.CD010952.pub2-BIB0059|cit59","first-page":"148","article-title":"A double-blind, crossover comparison of ketoprofen and indomethacin in ankylosing spondylitis","volume":"8","author":"Kennedy","year":"1991","journal-title":"Advances in Therapy"},{"issue":"22","key":"10.1002\/14651858.CD010952.pub2-BIB0060|cit60","first-page":"1454","article-title":"Evaluation of indomethacin by a controlled, cross-over technique in 30 patients with ankylosing spondylitis","volume":"96","author":"Kinsella","year":"1967","journal-title":"Canadian Medical Association Journal"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD010952.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/BF03258218","article-title":"Tenoxicam versus diclofenac in patients with ankylosing spondylitis. A double-blind study","volume":"2","author":"Mayrhofer","year":"1990","journal-title":"Drug Investigation"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1471-2474-12-165","article-title":"Longitudinal numbers-needed-to-treat (NNT) for achieving various levels of analgesic response and improvement with etoricoxib, naproxen, and placebo in ankylosing spondylitis","volume":"12","author":"Peloso","year":"2011","journal-title":"BMC Musculoskeletal Disorders"},{"issue":"2A","key":"10.1002\/14651858.CD010952.pub2-BIB0063|cit63","first-page":"324","article-title":"A double blind comparison of naproxen and indomethacin on the after-midnight-pain of patients with morbus bechterew","volume":"25","author":"Peter","year":"1975","journal-title":"Arzneimittel-Forschung"},{"issue":"11-2","key":"10.1002\/14651858.CD010952.pub2-BIB0064|cit64","first-page":"406","article-title":"Azapropazone versus indomethacin in a double blind test with patients with ankylosing spondylitis","volume":"39","author":"Sadowska-Wroblewska","year":"1980","journal-title":"Zeitschrift f\u00fcr Rheumatologie"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1055\/s-2008-1052326","article-title":"An open long-term study of piroxicam in ankylosing spondylitis patients","volume":"5","author":"Schattenkirchner","year":"1980","journal-title":"Aktuelle Rheumatologie"},{"issue":"2","key":"10.1002\/14651858.CD010952.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/rheumatology\/19.2.122","article-title":"A double-blind cross-over trial of indomethacin, fenoprofen and placebo in ankylosing spondylitis, with comments on patient assessment","volume":"19","author":"Shipley","year":"1980","journal-title":"Rheumatology and Rehabilitation"},{"issue":"1","key":"10.1002\/14651858.CD010952.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/annrheumdis-2013-203460","article-title":"Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2","volume":"73","author":"Sieper","year":"2014","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"6","key":"10.1002\/14651858.CD010952.pub2-BIB0068|cit68","first-page":"229","article-title":"A controlled study of flufenamic acid in ankylosing spondylitis. A final report and follow-up study","volume":"9","author":"Simpson","year":"1968","journal-title":"Annals of Physical Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010952.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/ard.33.2.129","article-title":"Double-blind cross-over comparison of indomethacin, flurbiprofen, and placebo in ankylosing spondylitis","volume":"33","author":"Sturrock","year":"1974","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010952.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/030006057700502S20","article-title":"A controlled comparative trial of Butacote and fenclofenac in the treatment of ankylosing spondylitis","volume":"5","author":"Thompson","year":"1977","journal-title":"Journal of International Medical Research"},{"issue":"1","key":"10.1002\/14651858.CD010952.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/ard.37.1.85","article-title":"Double-blind trial of naproxen and phenylbutazone in ankylosing spondylitis","volume":"37","author":"Gerwen","year":"1978","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"19","key":"10.1002\/14651858.CD010952.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1001\/jama.1981.03320190026021","article-title":"Nonsteroidal anti-inflammatory agents in rheumatoid arthritis and ankylosing spondylitis","volume":"246","author":"Wasner","year":"1981","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD010952.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/rheumatology\/19.4.260","article-title":"A double-blind cross-over trial of fenoprofen and phenylbutazone in ankylosing spondylitis","volume":"19","author":"Wordsworth","year":"1980","journal-title":"Rheumatology and Rehabilitation"},{"issue":"7","key":"10.1002\/14651858.CD010952.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jama.1966.03100200091027","article-title":"A nonsteroidal anti-inflammatory agent. Indomethacin (indocin)","volume":"196","author":"Unknown","year":"1966","journal-title":"JAMA"},{"issue":"46","key":"10.1002\/14651858.CD010952.pub2-BIB0075|cit75","first-page":"3229","article-title":"Clinical study of Bi-Profenid in rheumatologic practice","volume":"59","author":"Acqaviva","year":"1983","journal-title":"La Semaine des H\u00f4pitaux"},{"issue":"2A","key":"10.1002\/14651858.CD010952.pub2-BIB0076|cit76","first-page":"315","article-title":"Clinical results of a multicentral double-blind examination of naproxen compared to indomethacin in chronic rheumatoid arthritis, ankylosing spondylitis, and osteoarthrosis","volume":"25","author":"Aeidler","year":"1975","journal-title":"Arzneimittel-Forschung"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0077|cit77","first-page":"4958","article-title":"Comparison between sustained release formulations of ibuprofen and indomethacin in treatment of ankylosing spondylitis","volume":"34","author":"Bachmann","year":"1984","journal-title":"Therapiewoche"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0078|cit78","first-page":"17","article-title":"Efficacy and tolerance of oral hydrolytic enzymes in ankylosing spondylitis as compared with indomethacin: A controlled double-blind prospective clinical trial","volume":"2","author":"Baerwald","year":"1999","journal-title":"Journal of Clinical Research"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0079|cit79","first-page":"79","article-title":"Ethophenamate injections in treatment of acute painful conditions in rheumatic diseases","author":"Becvar","year":"1994","journal-title":"Ceska Revmatologie"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0080|cit80","first-page":"219","article-title":"Double-blind study using flufenamic acid (F.I. 440) and oxyphenylbutazone in rheumatoid arthritis and ankylosing spine","volume":"12","author":"Beltr\u00e1n Guti\u00e9rrez","year":"1968","journal-title":"Revista Espa\u00f1ola de Reumatismo y Enfermedades Osteo-Articulares"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0081|cit81","first-page":"6","article-title":"A comparison of the efficacy and tolerability of lornoxicam and indomethacin in ankylosing spondylitis","volume":"12","author":"Bernstein","year":"1992","journal-title":"European Journal of Rheumatology and Inflammation"},{"issue":"7","key":"10.1002\/14651858.CD010952.pub2-BIB0082|cit82","first-page":"457","article-title":"A parallel group comparison of tenoxicam and piroxicam in patients with ankylosing spondylitis","volume":"4","author":"Bird","year":"1986","journal-title":"Pharmatherapeutica"},{"issue":"1","key":"10.1002\/14651858.CD010952.pub2-BIB0083|cit83","first-page":"1","article-title":"Controlled clinical study of the therapeutic activity and side-effects of a preparation of indomethacin in lactocomplex","volume":"24","author":"Bocci","year":"1972","journal-title":"Reumatismo"},{"issue":"7","key":"10.1002\/14651858.CD010952.pub2-BIB0085|cit84","first-page":"107","article-title":"Double-blind trial of the therapeutic efficacy of voltaren and indomethacin in Bechterew's disease","volume":"53","author":"Burdeinyi","year":"1981","journal-title":"Terapevticheskii Arkhiv"},{"issue":"7","key":"10.1002\/14651858.CD010952.pub2-BIB0084|cit85","first-page":"107","article-title":"Double blind trial of voltaren and indomethacin in Bechterew's disease","volume":"53","author":"Burde\u012dn\u012d","year":"1981","journal-title":"Terapevticheski\u012d Arkhiv"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD010952.pub2-BIB0086|cit86","first-page":"49","article-title":"Double-blind, placebo-controlled clinical study over 52 weeks on M. Bechterew patients with 20 mg Piroxicam, 15 mg and 22,5 mg Meloxicam","volume":"59","author":"Dougados","year":"2000","journal-title":"Zeitschrift f\u00fcr Rheumatologie"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0087|cit87","first-page":"8901","article-title":"Tolmetin 400 mg capsules in treatment of ankylosing spondylitis","volume":"29","author":"Droste","year":"1979","journal-title":"Therapiewoche"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0088|cit88","first-page":"173","article-title":"Pirprofen in the treatment of ankylosing spondylitis. A 3-week open trial","volume":"103","author":"Droste","year":"1985","journal-title":"Fortschritte der Medizin"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0089|cit89","first-page":"115","article-title":"Treatment with tolmetin in ankylosing spondylitis. Comparative cross-study with phenylbutazone","volume":"55","author":"Dutu","year":"1982","journal-title":"Clujul Medical"},{"issue":"27-8","key":"10.1002\/14651858.CD010952.pub2-BIB0090|cit90","first-page":"1335","article-title":"Bumadizone-calcium-semihydrate (Eumotol) and oxyphenbutazone in the treatment of ankylosing spondylitis. A clinical double-blind study","volume":"26","author":"Franke","year":"1975","journal-title":"Die Medizinische Welt"},{"issue":"33","key":"10.1002\/14651858.CD010952.pub2-BIB0091|cit91","first-page":"2491","article-title":"Pirprofen, indomethacin and placebo in ankylosing spondylitis. Double-blind comparison","volume":"11","author":"Jajic","year":"1982","journal-title":"La Nouvelle Presse M\u00e9dicale"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0092|cit92","first-page":"1679","article-title":"Clinical results of tanderil administration in gout and rheumatic pelvispondylitis","volume":"140","author":"Leng Levy","year":"1963","journal-title":"Journal de M\u00e9decine de Bordeaux et du Sud-Ouest"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0093|cit93","first-page":"1226","article-title":"Results of a controlled double-blind comparison of Exrheudon and phenylbutazone","volume":"31","author":"Maier-Lenz","year":"1981","journal-title":"Therapiewoche"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0094|cit94","first-page":"121","article-title":"The efficacy and tolerance of NSAIDs in patients with ankylosing spondylitis","volume":"6","author":"Mayrhofer","year":"1991","journal-title":"Therapiewoche Osterreich"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0095|cit95","first-page":"3274","article-title":"Efficacy and tolerance of proquazone in ankylosing spondylarthritis","volume":"31","author":"Mertz","year":"1981","journal-title":"Therapiewoche"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0096|cit96","first-page":"8899","article-title":"Tolmetin treatment for ankylosing spondylitis","volume":"29","author":"M\u00fcller-Fassbender","year":"1979","journal-title":"Therapiewoche"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0097|cit97","first-page":"335","article-title":"Treatment of ankylosing spondylitis with tolmetin in doses of 800 or 1200 mg","volume":"7","author":"M\u00fcller-Fassbender","year":"1981","journal-title":"Verhandlungen der Deutschen Gesellschaft f\u00fcr Rheumatologie"},{"issue":"1","key":"10.1002\/14651858.CD010952.pub2-BIB0098|cit98","first-page":"66","article-title":"Evaluation of efficacy and tolerance of oral indoprofen in patients with ankylosing spondylitis","volume":"10","author":"Orozco Medina","year":"1983","journal-title":"Investigaci\u00f3n M\u00e9dica Internacional"},{"issue":"7A","key":"10.1002\/14651858.CD010952.pub2-BIB0099|cit99","first-page":"207","article-title":"Ankylosing spondylitis: efficacy, safety and therapeutic benefit of etodolac (600 mg daily) versus piroxicam (20 mg daily)","volume":"42","author":"Pattin","year":"1990","journal-title":"Rhumatologie"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0100|cit100","first-page":"7209","article-title":"Ankylosing spondylitis: comparison of acemetacin and piroxicam","volume":"34","author":"Reiter","year":"1984","journal-title":"Therapiewoche"},{"issue":"33","key":"10.1002\/14651858.CD010952.pub2-BIB0101|cit101","first-page":"2494","article-title":"Ankylosing spondylitis. Comparative trial of two non-steroidal anti-inflammatory agents: pirprofen and ketoprofen","volume":"11","author":"Renier","year":"1982","journal-title":"La Nouvelle Presse M\u00e9dicale"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0102|cit102","first-page":"2979","article-title":"Long-time results of Felden (piroxicam) in ankylosing spondylitis","volume":"31","author":"Schattenkirchner","year":"1981","journal-title":"Therapiewoche"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0103|cit103","first-page":"5276","article-title":"Treatment of ankylosing spondylitis: Single-blind crossover comparison of acemetacin and diclofenac","volume":"36","author":"Schattenkirchner","year":"1986","journal-title":"Therapiewoche"},{"issue":"9","key":"10.1002\/14651858.CD010952.pub2-BIB0104|cit104","first-page":"283","article-title":"A comparative study of pirprofene and phenylbutazone in the treatment of ankylosing spondylitis","volume":"39","author":"Simon","year":"1987","journal-title":"Rheumatologie"},{"issue":"20","key":"10.1002\/14651858.CD010952.pub2-BIB0105|cit105","first-page":"561","article-title":"Comparative study of the treatment of ankylosing spondylitis with piroxicam suppositories and indomethacin suppositories in combination with indomethacin retard capsules","volume":"103","author":"Stollenwerk","year":"1985","journal-title":"Fortschritte der Medizin"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0106|cit106","unstructured":"NCT01934933 Delaying Ossification and Improving Inflammation of Celebrex Plus\/or Enbrel Treatment on Active Ankylosing Spondylitis http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01934933?type=Intr&cond=Spondylitis&rcv_s=06%2F01%2F2013&rank=2"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0107|cit107","unstructured":"NCT02089529 Treatment of Axial Spondyloarthritis With Reduced Doses of NSAIDs http:\/\/clinicaltrials.gov\/ct2\/show\/NCT02089529?type=Intr&cond=Spondylitis&rcv_s=06%2F01%2F2013&rank=9"},{"issue":"2","key":"10.1002\/14651858.CD010952.pub2-BIB0108|cit108","first-page":"85","article-title":"Criteria of the classification of spondyloarthropathies","volume":"57","author":"Amor","year":"1990","journal-title":"Revue du rhumatisme et des maladies ost\u00e9o-articulaires"},{"issue":"8","key":"10.1002\/14651858.CD010952.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F","article-title":"Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis","volume":"44","author":"Anderson","year":"2001","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1002\/14651858.CD010952.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/gut.28.5.527","article-title":"Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration","volume":"28","author":"Armstrong","year":"1987","journal-title":"Gut"},{"issue":"7454","key":"10.1002\/14651858.CD010952.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"10","key":"10.1002\/14651858.CD010952.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2174\/0929867024606650","article-title":"Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks","volume":"9","author":"Bertolini","year":"2002","journal-title":"Current Medicinal Chemistry"},{"issue":"9894","key":"10.1002\/14651858.CD010952.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"Bhala","year":"2013","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD010952.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/ard.2003.016717","article-title":"Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis","volume":"63","author":"Brandt","year":"2004","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"5","key":"10.1002\/14651858.CD010952.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/art.21790","article-title":"Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study","volume":"54","author":"Braun","year":"2006","journal-title":"Arthritis and Rheumatism"},{"issue":"9570","key":"10.1002\/14651858.CD010952.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","article-title":"Ankylosing spondylitis","volume":"369","author":"Braun","year":"2007","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD010952.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","article-title":"2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"70","author":"Braun","year":"2011","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"11","key":"10.1002\/14651858.CD010952.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010952.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/annrheumdis-2011-201244","article-title":"Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease","volume":"72","author":"Burmester","year":"2013","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"12","key":"10.1002\/14651858.CD010952.pub2-BIB0120|cit120","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index","volume":"21","author":"Calin","year":"1994","journal-title":"Journal of Rheumatology"},{"issue":"9736","key":"10.1002\/14651858.CD010952.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(10)60673-3","article-title":"Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial","volume":"376","author":"Chan","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0122|cit122","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"10","key":"10.1002\/14651858.CD010952.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","article-title":"The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy","volume":"34","author":"Dougados","year":"1991","journal-title":"Arthritis and Rheumatism"},{"issue":"4","key":"10.1002\/14651858.CD010952.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/rheumatology\/34.4.301","article-title":"Diagnostic features of ankylosing spondylitis","volume":"34","author":"Dougados","year":"1995","journal-title":"British Journal of Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD010952.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"249\u201351","DOI":"10.1136\/ard.2010.133488","article-title":"ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials\/ epidemiological studies in axial spondyloarthritis","volume":"70","author":"Dougados","year":"2011","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"10.1002\/14651858.CD010952.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.62.1.20","article-title":"Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis","volume":"62","author":"Doward","year":"2003","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"9196","key":"10.1002\/14651858.CD010952.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(99)02332-6","article-title":"Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison","volume":"354","author":"Emery","year":"1999","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD010952.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/rheumatology\/keq078","article-title":"Evaluation of the treatment effect of NSAIDs\/TNF blockers according to different domains in ankylosing spondylitis: results of a meta-analysis","volume":"49","author":"Escalas","year":"2010","journal-title":"Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD010952.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archinte.162.3.265","article-title":"Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study","volume":"162","author":"Feenstra","year":"2002","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0130|cit130","first-page":"6","article-title":"NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal","volume":"28","author":"Fries","year":"1991","journal-title":"Journal of Rheumatology Supplement"},{"issue":"10","key":"10.1002\/14651858.CD010952.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7326\/0003-4819-115-10-787","article-title":"Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis","volume":"115","author":"Gabriel","year":"1991","journal-title":"Annals of Internal Medicine"},{"issue":"12","key":"10.1002\/14651858.CD010952.pub2-BIB0132|cit132","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"Journal of Rheumatology"},{"issue":"11","key":"10.1002\/14651858.CD010952.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1136\/ard.2004.029611","article-title":"Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis","volume":"64","author":"Gossec","year":"2005","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"5","key":"10.1002\/14651858.CD010952.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"359","DOI":"10.7326\/0003-4819-109-5-359","article-title":"Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons","volume":"109","author":"Griffin","year":"1988","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010952.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"427","DOI":"10.7326\/0003-4819-144-6-200603210-00010","article-title":"Evaluation of the quality of prognosis studies in systematic reviews","volume":"144","author":"Hayden","year":"2006","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0136|cit136","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0137|cit137","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0138|cit138","unstructured":"Higgins JPT Deeks JJ (editors) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"9","key":"10.1002\/14651858.CD010952.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1136\/ard.2008.092213","article-title":"MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a short course of etoricoxib","volume":"68","author":"Jarrett","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"9","key":"10.1002\/14651858.CD010952.pub2-BIB0140|cit140","first-page":"1694","article-title":"Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index","volume":"21","author":"Jenkinson","year":"1994","journal-title":"Journal of Rheumatology"},{"issue":"7553","key":"10.1002\/14651858.CD010952.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials","volume":"332","author":"Kearney","year":"2006","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD010952.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/art.1780280107","article-title":"Spondylitic disease without radiologic evidence of sacroiliitis in relatives of HLA-B27 positive ankylosing spondylitis patients","volume":"28","author":"Khan","year":"1985","journal-title":"Arthritis and Rheumatism"},{"issue":"2","key":"10.1002\/14651858.CD010952.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0049-0172(90)90023-9","article-title":"A wider spectrum of spondyloarthropathies","volume":"20","author":"Khan","year":"1990","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"10","key":"10.1002\/14651858.CD010952.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1136\/annrheumdis-2012-201370","article-title":"Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis","volume":"71","author":"Kroon","year":"2012","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"8905","key":"10.1002\/14651858.CD010952.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(94)90185-6","article-title":"Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs","volume":"343","author":"Langman","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0146|cit146","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"7119","key":"10.1002\/14651858.CD010952.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1136\/bmj.315.7119.1333","article-title":"Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study","volume":"315","author":"MacDonald","year":"1997","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD010952.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1136\/ard.2009.124206","article-title":"Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis","volume":"69","author":"Machado","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"10","key":"10.1002\/14651858.CD010952.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1136\/ard.2011.150037","article-title":"A stratified model for health outcomes in ankylosing spondylitis","volume":"70","author":"Machado","year":"2011","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"10.1002\/14651858.CD010952.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2010.138594","article-title":"Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores","volume":"70","author":"Machado","year":"2011","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"7","key":"10.1002\/14651858.CD010952.pub2-BIB0151|cit151","first-page":"1109","article-title":"Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup","volume":"15","author":"Mau","year":"1988","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.pa.33.040193.002251","article-title":"Renal toxicity of the nonsteroidal anti-inflammatory drugs","volume":"33","author":"Murray","year":"1993","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"10","key":"10.1002\/14651858.CD010952.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/00005650-200110000-00002","article-title":"Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life","volume":"39","author":"Norman","year":"2001","journal-title":"Medical Care"},{"issue":"9","key":"10.1002\/14651858.CD010952.pub2-BIB0154|cit154","first-page":"1953","article-title":"Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography. A prospective, longitudinal study","volume":"26","author":"Oostveen","year":"1999","journal-title":"Journal of Rheumatology"},{"issue":"10","key":"10.1002\/14651858.CD010952.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1136\/annrheumdis-2011-201252","article-title":"Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort","volume":"71","author":"Poddubnyy","year":"2012","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"8","key":"10.1002\/14651858.CD010952.pub2-BIB0156|cit156","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1136\/annrheumdis-2014-205178","article-title":"Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort","volume":"73","author":"Ramiro","year":"2014","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0157|cit157","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0158|cit158","first-page":"S211","article-title":"The burden of disease in patients with ankylosing spondylitis (AS) and pre-radiographic axial spondyloarthritis","volume":"50","author":"Rudwaleit","year":"2004","journal-title":"Arthritis and Rheumatism"},{"issue":"4","key":"10.1002\/14651858.CD010952.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/art.20990","article-title":"The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria?","volume":"52","author":"Rudwaleit","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"6","key":"10.1002\/14651858.CD010952.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/ard.2009.108217","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"6","key":"10.1002\/14651858.CD010952.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"6","key":"10.1002\/14651858.CD010952.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/1529-0131(200006)43:6<1356::AID-ANR20>3.0.CO;2-Y","article-title":"The familial form of spondylarthropathy: a clinical study of 115 multiplex families. Groupe Francais d'Etude Genetique des Spondylarthropathies","volume":"43","author":"Said-Nahal","year":"2000","journal-title":"Arthritis and Rheumatism"},{"issue":"3","key":"10.1002\/14651858.CD010952.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s100670170066","article-title":"Undifferentiated spondyloarthropathies: a 2-year follow-up study","volume":"20","author":"Sampaio-Barros","year":"2001","journal-title":"Clinical Rheumatology"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0164|cit164","unstructured":"Sch\u00fcnemann H Oxman A Higgins J Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD010952.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/1529-0131(199801)41:1<122::AID-ART15>3.0.CO;2-8","article-title":"Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases","volume":"41","author":"Siegle","year":"1998","journal-title":"Arthritis and Rheumatism"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010952.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","article-title":"The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis","volume":"68","author":"Sieper","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"10","key":"10.1002\/14651858.CD010952.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"issue":"20","key":"10.1002\/14651858.CD010952.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1001\/jama.282.20.1921","article-title":"Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial","volume":"282","author":"Simon","year":"1999","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD010952.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00004836-199310000-00014","article-title":"NSAID-induced gastroduodenal damage: is prevention needed? A review and metaanalysis","volume":"17","author":"Stalnikowicz","year":"1993","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0170|cit170","unstructured":"Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD010952.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.rdc.2012.09.003","article-title":"Epidemiology of spondyloarthritis","volume":"38","author":"Stolwijk","year":"2012","journal-title":"Rheumatic Diseases Clinics of North America"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"c7086","DOI":"10.1136\/bmj.c7086","article-title":"Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis","volume":"342","author":"Trelle","year":"2011","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD010952.pub2-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/rheumatology\/kes066","article-title":"First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS\/ EULAR management recommendations in ankylosing spondylitis","volume":"51","author":"Berg","year":"2012","journal-title":"Rheumatology"},{"issue":"10","key":"10.1002\/14651858.CD010952.pub2-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1002\/art.23901","article-title":"Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis","volume":"58","author":"Heijde","year":"2008","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1002\/14651858.CD010952.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.23471","article-title":"Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept","volume":"58","author":"Heijde","year":"2008","journal-title":"Arthritis and Rheumatism"},{"issue":"12","key":"10.1002\/14651858.CD010952.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/ard.2008.100826","article-title":"ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis","volume":"68","author":"Heijde","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4","key":"10.1002\/14651858.CD010952.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/ar2794","article-title":"Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years","volume":"11","author":"Heijde","year":"2009","journal-title":"Arthritis Research & Therapy"},{"issue":"6","key":"10.1002\/14651858.CD010952.pub2-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/ard.2011.151563","article-title":"2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis","volume":"70","author":"Heijde","year":"2011","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4","key":"10.1002\/14651858.CD010952.pub2-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"Linden","year":"1984","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1002\/14651858.CD010952.pub2-BIB0181|cit181","unstructured":"Dr Christopher Cates' EBM Web Site Visual Rx 2008"},{"issue":"8","key":"10.1002\/14651858.CD010952.pub2-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/art.20446","article-title":"What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter","volume":"50","author":"Wanders","year":"2004","journal-title":"Arthritis and Rheumatism"},{"issue":"6","key":"10.1002\/14651858.CD010952.pub2-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.21054","article-title":"Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial","volume":"52","author":"Wanders","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"6","key":"10.1002\/14651858.CD010952.pub2-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medical Care"},{"issue":"11","key":"10.1002\/14651858.CD010952.pub2-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1172\/JCI0215681","article-title":"Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair","volume":"109","author":"Zhang","year":"2002","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"10.1002\/14651858.CD010952.pub2-BIB0186|cit186","first-page":"423\u201332","article-title":"Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS\/EULAR management recommendations in ankylosing spondylitis","volume":"65","author":"Zochling","year":"2006","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"10.1002\/14651858.CD010952.pub2-BIB0187|cit187","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010952","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)","author":"Kroon","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD010952.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:49:01Z","timestamp":1759999741000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010952.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Musculoskeletal Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,17]]},"references-count":187,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010952.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,17]]}}}